Forty-one percent of elite endurance athletes follow a gluten-free diet. Most of them do not have coeliac disease. The question that the science keeps asking — and most sports nutrition influencers keep ignoring — is whether gluten-free eating offers any actual performance advantage for athletes without a diagnosed condition.
The answer, based on the best available evidence, is almost certainly no. But the story of how we got here is worth understanding.
---
Non-coeliac gluten sensitivity (NCGS) was proposed as a clinical entity after a 2011 double-blind crossover trial by Biesiekierski and colleagues (Gastroenterology) found that individuals who reported GI symptoms with gluten but tested negative for coeliac disease showed significantly worse GI symptoms and fatigue during a gluten-containing period versus placebo. NCGS appeared real.
Then the same research group returned in 2013 with a more carefully controlled study. When FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) were removed from both the gluten and placebo conditions, gluten-specific effects disappeared entirely. Biesiekierski 2013 (Gastroenterology) concluded that gluten itself was not driving symptoms in the NCGS cohort — fermentable carbohydrates in wheat were. This is now the dominant mechanistic explanation.
---
The athlete-specific study came from Lis and colleagues (2015, Medicine and Science in Sports and Exercise). Thirteen competitive cyclists were randomised to a 7-day gluten-containing or gluten-free diet in a double-blind crossover design. There were no differences in GI symptoms, well-being, training capacity, or any performance marker between conditions. The authors concluded there was no evidence to support a GFD for performance benefit in non-coeliac athletes.
What the data does show is a robust nocebo effect. When athletes believe they are consuming gluten, they report more GI distress — regardless of whether the food contains any. This psychonociceptive mechanism is well-documented and appears to account for a meaningful proportion of self-reported gluten sensitivity in athletes.
Wheat amylase trypsin inhibitors (ATIs) — not gluten — may trigger innate immune responses in some individuals via TLR4 receptor activation (Junker 2012). This may represent a distinct wheat sensitivity that is not gluten-mediated and may or may not improve on a gluten-free diet.
---
The practical risks of unnecessary GFD in athletes are real:
- Reduced fibre intake: Gluten-free grains are lower in fibre and prebiotic content, which can reduce gut microbiome diversity
- Reduced B-vitamin intake: Fortification requirements for GFD products differ by jurisdiction; folate, thiamine and riboflavin gaps are common
- Increased cost without benefit: Premium GFD products cost 2–3x conventional equivalents
- Social restriction: Travelling athletes face significantly reduced food access on strict GFD without coeliac necessity
The one context where a careful elimination protocol makes legitimate sense is in athletes who have persistent GI distress during training and racing that has not responded to standard gut training strategies. In this population, a systematic low-FODMAP elimination and reintroduction protocol — not a blanket gluten-free approach — is the evidence-based first step.
Athletes following ancestral-style eating patterns that already emphasise whole, unprocessed foods tend to naturally reduce wheat intake without the restrictions and costs of a medicalised GFD. For athletes calculating macronutrient targets within a whole-food, lower-grain framework, the free tool at winsport.uk/tools/nutrition/paleo-diet-macros estimates macro distributions for training and rest days based on bodyweight and goals.
Do you or does someone you coach follow a gluten-free diet — and has an elimination-reintroduction trial ever been done to establish whether it actually helps?